Target intelligence / Profile preview

Double homeobox 4 like 12 (pseudogene) (DUX4L12)

Target
DUX4L12
Molecular classification
Other (Pseudogene)
01

Overview

Double homeobox 4 like 12 (DUX4L12) is a human pseudogene closely related in sequence to the Double homeobox 4 (DUX4) gene, which encodes a functional transcription factor. DUX4 is involved in early embryonic gene regulation and is implicated in diseases including facioscapulohumeral muscular dystrophy and certain cancers[1][7][4][5]. However, DUX4L12 itself is classified as a pseudogene and is not known to be transcribed or translated into a functional protein. It does not have a molecular or therapeutic role in human biology and should not be conflated with DUX4, the active transcription factor. Any drug discovery or disease research relevance should instead focus on DUX4 rather than DUX4L12[3][6]. If information about DUX4 (Double homeobox 4), the functional transcription factor, is desired, please specify, as it has established roles in human disease[1][7][4][5][6].

Other names
Double homeobox 4 like 12 (pseudogene)DUX4L12Double homeobox, 4 pseudogene
02

Mechanism of action

Not applicable. Drugs and interventions targeting DUX4L12 have not been reported.

03

Biological functions

None known. DUX4L12 is a pseudogene and is not known to encode a functional protein or perform any biological function in humans[3][6].
04

Disease associations

None established for DUX4L12 specifically. Disease associations and functional roles are attributed to DUX4, not DUX4L12[1][7][4][5].
05

Safety considerations

None specific to DUX4L12 as a pseudogene.
06

Interacting drugs

None known. No drugs target DUX4L12; any therapeutic interest is directed towards DUX4[3][6].
07

Biomarkers

None known for DUX4L12.

Beyond the preview

Go deeper on Double homeobox 4 like 12 (pseudogene) (DUX4L12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Double homeobox 4 like 12 (pseudogene) (DUX4L12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call